One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening

Archives of Disease in Childhood

Volumn 95, Issue 10, 2010, Pages 822-825

  Peters, Marjolein ^a   Fijnvandraat, K ^a   Van Den Tweel, X W ^a   Garre, F G ^b   Giordano, P C ^c   Van Wouwe, J P ^b   Pereira, R R ^b   Verkerk, P H ^b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b TNO   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CHILD HEALTH CARE; HEALTH PROGRAM; HUMAN; IMMIGRANT; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; NETHERLANDS; NEWBORN SCREENING; PEDIATRICIAN; PREVALENCE; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; CHILD HEALTH SERVICES; CHILD, PRESCHOOL; EMIGRANTS AND IMMIGRANTS; HUMANS; INFANT; INFANT, NEWBORN; NEONATAL SCREENING; NETHERLANDS; PREVALENCE;

EID: 77957334334     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.165290     Document Type: Article

References (17)

1. Bolhuis PA, Page-Christiaens GC. [The advisory report 'Neonatal screening' from the Health Council of The Netherlands]. Ned Tijdschr Geneeskd 2005;149:2857-60.
2. Steinberg MH, Forget BG, Higgs DR, et al. Disorders of hemoglobin: genetics, pathophysiology and clinical management. 1st edn. Cambridge: Cambridge University Press, 2001.
3. Modell B, Darlison M, Birgens H, et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest 2007;67:39-69.
4. Howard J, Davies SC. Sickle cell disease in North Europe. Scand J Clin Lab Invest 2007;67:27-38.
5. Vansenne F, de Borgie CA, Bouva MJ, et al. [Sickle cell disease in heel prick screening. II]. Ned Tijdschr Geneeskd 2009;153:858-61.
6. van den Tweel X, Heijboer H, Fijnvandraat K, et al. Identifying children with sickle cell anaemia in a non-endemic country: age at diagnosis and presenting symptoms. Eur J Pediatr 2006;165:581-2.
7. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986;314:1593-9.
8. Riddington C, Owusu-Ofori S. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database Syst Rev 2002;3:CD003427.
9. Vichinsky EP. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Hematol 1991;28:220-6.
10. Section on Hematology/Oncology Committee on Genetics; American Academy of Pediatrics. Health supervision for children with sickle cell disease. Pediatrics 2002;109:526-35.
11. Mayor S. UK enquiry shows lack of knowledge about complications in patients with sickle cell disease. BMJ 2008;336:1152.
12. Lucas SB, Mason DG, Mason M, et al. A Sickle Crisis? A Report of the National Confidential Enquiry into Patient Outcome and Death. 2008.
13. Hirasing RA, Rodrigues PR. [The Dutch pediatric surveillance system; a quality focuesd instrument for prevention and research]. Ned Tijdschr Geneesk 2002;146:2409-14.
14. Wittes J, Sidel VW. A generalization of the simple capture-recapture model with applications to epidemiological research. J Chronic Dis 1968;21:287-301.
15. Hook EB, Regal RR. Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev 1995;17:243-64.
16. Rengelink-van der Lee JH, Schulpen TW, Beemer FA. [Incidence and prevalence of hemoglobinopathies in children in The Netherlands]. Ned Tijdschr Geneesk 1995;139:1498-501.
17. Giordano PC, Bouva MJ, Harteveld CL. A confidential inquiry estimating the number of patients affected with sickle cell disease and thalassemia major confirms the need for a prevention strategy in The Netherlands. Hemoglobin 2004;28:287-96.